Chemo Pharma Laboratories Ltd. (BSE: 506365) is a Mumbai, Maharashtra-based company in the Pharmaceuticals industry. With a market capitalisation of ₹15 Cr, it ranks #4,583 by market cap among the 6,197 Indian listed companies on FinBizNet, and #2 of 2 in Pharmaceuticals. At ₹100.20 (as of 16 Nov 2026), the share price is 34.5% below its 52-week high of ₹152.90 and 43.1% above its 52-week low of ₹70.01. The share price is down 18.2% over one year and up 12.9% over three months.
| Current Price | ₹100.20 |
|---|---|
| Market Cap | ₹15 Cr |
| BSE Code | 506365 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals |
| P/E Ratio | Not meaningful (loss) |
| Return on Equity | -1.64% |
| Return on Assets | -97.73% |
| 52-Week Range | ₹70.01 – ₹152.90 |
| 1-Year Price Change | -18.2% |
| 3-Month Price Change | +12.9% |
| Beta (1Y) | -0.07 |
| Headquarters | Mumbai, Maharashtra |
| Website | www.thechemopharmalaboratoriesltd.com |
Promoters held 67.68% of Chemo Pharma Laboratories Ltd.'s shares as of Jun 2026, unchanged from Jun 2025. Delivery averaged 100.0% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).
Starsource Multitrade Limited does not have significant operations. The company was previously engaged in the production of pharmaceutical and bulk drug products. The company was formerly known as Chemo Pharma Laboratories Limited and changed its name to Starsource Multitrade Limited in October 2025. The company was incorporated in 1942 and is based in Mumbai, India.
1. Unclassified Services-This segment offers pharmaceutical products. 2. 0-0 3. 0-0 4. 0-0
1. Unclassified Services-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Macro (International) Exports Ltd. | ₹270 Cr | 8 | 7.96% | — | -34.0% |
| Chemo Pharma Laboratories Ltd. | ₹15 Cr | n/m | -1.64% | — | -18.2% |
Listed by market capitalisation. Ratios are shown for context only.
Chemo Pharma Laboratories Ltd. is trading at ₹100.20, with a market capitalisation of ₹15 Cr.
Chemo Pharma Laboratories Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals).
Chemo Pharma Laboratories Ltd. has a return on equity of -1.64%.
Chemo Pharma Laboratories Ltd. is listed on the BSE under the scrip code 506365.
Chemo Pharma Laboratories Ltd.'s share price is down 18.2% over one year and up 12.9% over three months. Its 52-week range is ₹70.01 to ₹152.90.
Promoters held 67.68% of Chemo Pharma Laboratories Ltd.'s shares as of Jun 2026, unchanged from Jun 2025.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.